<DOC>
	<DOCNO>NCT00327028</DOCNO>
	<brief_summary>The purpose study evaluation efficacy antiepileptic drug phenytoin ( diphenine ) treatment bronchial asthma .</brief_summary>
	<brief_title>Study Efficacy Phenytoin Therapy Patients With Bronchial Asthma</brief_title>
	<detailed_description>Effective therapy asthma still remain quite serious problem . According current opinion lead specialist , asthma inflammatory disorder . But asthma also paroxysmal disorder : many specialist underline paroxysmal clinical picture asthma . According author , neurogenic inflammation may play important role asthma mechanism . But migraine trigeminal neuralgia also neurogenic inflammatory paroxysmal disease , antiepileptic drug , like diphenine valproates , effective therapy diseases - 80 % case . If bronchial asthma also paroxysmal inflammatory disease , suppose possibility antiepileptic drug also may show high efficacy asthma therapy . Taken consideration hypothesis , perform double-blind , placebo-controlled 3-month trial evaluation phenytoin ( diphenine ) efficacy treatment patient bronchial asthma .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Phenytoin</mesh_term>
	<criteria>Out patient Bronchial asthma know least 1 year Absence longterm remission asthma ( last 1 month ) Poorly control asthma , due various reason Nonsmokers Presence concomitant acute chronic severe diseases Abnormal baseline haematology , blood chemistry urinalysis Allergy adverse reaction investigational drug Age young 18 year old Longterm history smoking Pregnancy lactating</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Bronchial asthma</keyword>
	<keyword>Phenytoin , Diphenine</keyword>
	<keyword>Antiepileptic drug</keyword>
	<keyword>Efficacy</keyword>
</DOC>